MMRF Molecular Profiling Protocol

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Multiple MyelomaPlasma Malignancy
Interventions
GENETIC

genetic sequencing

Trial Locations (20)

10029

Mount Sinai Medical Center, New York

28204

Levine Cancer Institute, Charlotte

30322

Emory University, Atlanta

32224

Mayo Clinic - Jacksonville, Jacksonville

37203

Sarah Cannon Research Institute, Nashville

43210

Ohio State University, Columbus

48109

University of Michigan, Ann Arbor

48201

Barbara Ann Karmanos Cancer Institute, Detroit

55905

Mayo Clinic - Rochester, Rochester

63110

Washington University, St Louis

75246

Baylor Research Institute, Dallas

85259

Mayo Clinic - Scottsdale, Scottsdale

91010

City of Hope, Duarte

94143

UCSF Medical Center, San Francisco

Unknown

University of Chicago, Chicago

Virginia Cancer Specialists, Fairfax

02114

Massachusetts General Hospital, Boston

02215

Dana-Farber Cancer Institute, Boston

07601

Hackensack University Medical Center, Hackensack

M5G 2C1

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

Multiple Myeloma Research Foundation

OTHER

NCT02884102 - MMRF Molecular Profiling Protocol | Biotech Hunter | Biotech Hunter